• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Neurotech International

Neurotech International

ASX:NTI

  • Home
  • Corporate
    • Board and Management
    • Corporate Directory
    • Corporate Governance
    • Corporate Videos
  • Development Programs
    • Biopharmaceutical Trials
    • Combination Therapy
    • Pathways to Commercialisation
    • Mente Technology
  • Investors
    • Investor Dashboard
    • ASX Announcements
    • Investor Conference Calls  
    • Company Reports
    • Presentations
    • Research
    • News & Media
    • Fact Sheets
  • Contact

Fact Sheets

Rett Syndrome Factsheet
PANDAS/PANS Fact Sheet
Orphan Drug Designation Fact Sheet
NTI164 Fact Sheet
Neurotech Value Proposition Fact Sheet
Autism Spectrum Disorder (ASD) Fact Sheet

Footer

Suite 5 CPC, 145 Stirling Highway
Nedlands WA 6009
Australia

moc.l1695796446anoit1695796446anret1695796446nihce1695796446torue1695796446n@ofn1695796446i1695796446

+61 (8) 9389 3130

Subscribe to our latest announcements

Name*
This field is for validation purposes and should be left unchanged.

Copyright © 2023 Neurotech International • Site by White Noise Communications

Download prospectus